BrainsWay Ltd. (BWAY)
USD 9.08
(-4.32%)
USD 9.08
(-4.32%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.31 Million USD | 67.8% |
| 2022 | -11.45 Million USD | -236.49% |
| 2021 | -4.59 Million USD | 31.39% |
| 2020 | -3.42 Million USD | 26.64% |
| 2019 | -8.47 Million USD | -49.55% |
| 2018 | -4.64 Million USD | 20.88% |
| 2017 | -5.67 Million USD | -278.76% |
| 2016 | -1.42 Million USD | 62.46% |
| 2015 | -3.43 Million USD | 43.03% |
| 2014 | -6.2 Million USD | -622.29% |
| 2013 | -4.06 Million USD | 82.94% |
| 2012 | -5.62 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 884 Thousand USD | 115.61% |
| 2024 Q1 | 410 Thousand USD | -74.12% |
| 2023 FY | - USD | 67.8% |
| 2023 Q2 | -1 Million USD | 69.98% |
| 2023 Q1 | -3.34 Million USD | 16.06% |
| 2023 Q4 | 523 Thousand USD | 162.81% |
| 2023 Q3 | 199 Thousand USD | 119.84% |
| 2022 Q1 | -1.09 Million USD | 24.59% |
| 2022 FY | - USD | -236.49% |
| 2022 Q4 | -3.98 Million USD | 10.88% |
| 2022 Q3 | -4.46 Million USD | -177.74% |
| 2022 Q2 | -1.6 Million USD | -46.85% |
| 2021 Q3 | -440 Thousand USD | 49.25% |
| 2021 Q1 | -1.46 Million USD | -258.97% |
| 2021 FY | - USD | 31.39% |
| 2021 Q2 | -867 Thousand USD | 40.66% |
| 2021 Q4 | -1.45 Million USD | -230.0% |
| 2020 Q2 | 360 Thousand USD | 112.49% |
| 2020 Q4 | -407 Thousand USD | -264.11% |
| 2020 FY | - USD | 26.64% |
| 2020 Q1 | -2.88 Million USD | -21.91% |
| 2020 Q3 | 248 Thousand USD | -31.11% |
| 2019 Q4 | -2.36 Million USD | -61.48% |
| 2019 Q2 | -1.63 Million USD | -30.25% |
| 2019 FY | - USD | -49.55% |
| 2019 Q1 | -1.25 Million USD | 46.45% |
| 2019 Q3 | -1.46 Million USD | 10.29% |
| 2018 Q4 | -2.34 Million USD | -338.2% |
| 2018 Q3 | -534 Thousand USD | 22.72% |
| 2018 FY | - USD | 20.88% |
| 2018 Q2 | -691 Thousand USD | -7.47% |
| 2018 Q1 | -643 Thousand USD | 78.23% |
| 2017 Q2 | -198 Thousand USD | 84.2% |
| 2017 Q4 | -2.95 Million USD | -181.51% |
| 2017 Q3 | -1.04 Million USD | -429.8% |
| 2017 Q1 | -1.25 Million USD | 20.95% |
| 2017 FY | - USD | -278.76% |
| 2016 Q1 | -714 Thousand USD | 63.53% |
| 2016 FY | - USD | 62.46% |
| 2016 Q4 | -1.58 Million USD | -400.0% |
| 2016 Q3 | -317 Thousand USD | -124.92% |
| 2016 Q2 | 1.27 Million USD | 278.15% |
| 2015 FY | - USD | 43.03% |
| 2015 Q4 | -1.95 Million USD | -2357.69% |
| 2015 Q3 | -79.66 Thousand USD | 76.1% |
| 2015 Q1 | -4 Million USD | -19.0% |
| 2015 Q2 | -333.35 Thousand USD | 91.68% |
| 2014 Q4 | -3.36 Million USD | -551.08% |
| 2014 FY | - USD | -622.29% |
| 2014 Q1 | -4.12 Million USD | -251.79% |
| 2014 Q3 | -517.15 Thousand USD | 29.27% |
| 2014 Q2 | -731.18 Thousand USD | 82.27% |
| 2013 Q3 | -1.16 Million USD | -104.37% |
| 2013 Q4 | -1.17 Million USD | -0.39% |
| 2013 FY | - USD | 82.94% |
| 2013 Q1 | -1.2 Million USD | 22.89% |
| 2013 Q2 | -571.23 Thousand USD | 52.76% |
| 2012 Q3 | -1.52 Million USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | -1.56 Million USD | -3.13% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 82.865% |
| Cerus Corporation | -26.53 Million USD | 91.291% |
| OrthoPediatrics Corp. | -8.38 Million USD | 72.426% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 77.979% |
| Talis Biomedical Corporation | -66.04 Million USD | 96.501% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 86.141% |
| Inogen, Inc. | -45.67 Million USD | 94.941% |
| Spectral AI, Inc. | -12.26 Million USD | 81.153% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 95.154% |
| CVRx, Inc. | -38.73 Million USD | 94.033% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 34.495% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 80.912% |
| Orthofix Medical Inc. | -86.98 Million USD | 97.343% |
| Venus Concept Inc. | -26.11 Million USD | 91.15% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 95.357% |
| Bioventus Inc. | -23.07 Million USD | 89.983% |
| Envoy Medical, Inc. | -18.23 Million USD | 87.329% |
| electroCore, Inc. | -17.76 Million USD | 86.988% |
| IceCure Medical Ltd | -15.25 Million USD | 84.849% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 95.355% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 86.289% |
| MaxCyte, Inc. | -44.12 Million USD | 94.763% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 80.342% |
| Nexalin Technology, Inc. | -5.69 Million USD | 59.399% |
| PAVmed Inc | -75.74 Million USD | 96.949% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 95.701% |
| RxSight, Inc. | -41.03 Million USD | 94.368% |
| Sight Sciences, Inc. | -49.41 Million USD | 95.323% |
| SI-BONE, Inc. | -34.44 Million USD | 93.291% |
| TELA Bio, Inc. | -40.63 Million USD | 94.313% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 96.036% |
| Treace Medical Concepts, Inc. | -39 Million USD | 94.076% |
| LivaNova PLC | 39.01 Million USD | 105.923% |
| 908 Devices Inc. | -34.02 Million USD | 93.208% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 97.91% |
| Nemaura Medical Inc. | -7.28 Million USD | 68.286% |
| NeuroPace, Inc. | -22.83 Million USD | 89.879% |
| LENSAR, Inc. | -8.71 Million USD | 73.479% |
| Apyx Medical Corporation | -18.11 Million USD | 87.241% |
| Cutera, Inc. | -136.56 Million USD | 98.308% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 31.627% |
| BioSig Technologies, Inc. | -28.15 Million USD | 91.791% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 191.852% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 88.989% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 100.602% |
| Axonics, Inc. | 7.77 Million USD | 129.723% |
| Outset Medical, Inc. | -153.78 Million USD | 98.497% |
| IRIDEX Corporation | -7.44 Million USD | 68.972% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 97.644% |
| IRadimed Corporation | 20.8 Million USD | 111.11% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 71.335% |
| INVO Bioscience, Inc. | -6.88 Million USD | 66.41% |
| Telesis Bio, Inc. | -40.49 Million USD | 94.293% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 106.301% |
| Varex Imaging Corporation | 67.2 Million USD | 103.439% |
| Quipt Home Medical Corp. | 44.07 Million USD | 105.244% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 78.74% |
| Pulmonx Corporation | -55.09 Million USD | 95.805% |
| Dynatronics Corporation | -976 Thousand USD | -136.781% |
| Modular Medical, Inc. | -17.1 Million USD | 86.488% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 84.046% |
| Semler Scientific, Inc. | 23.58 Million USD | 109.797% |
| InMode Ltd. | 196.28 Million USD | 101.177% |
| Bruker Corporation | 599 Million USD | 100.386% |
| Cytosorbents Corporation | -28.81 Million USD | 91.979% |
| DexCom, Inc. | 916.7 Million USD | 100.252% |
| Align Technology, Inc. | 799.03 Million USD | 100.289% |
| Viveve Medical, Inc. | -20.61 Million USD | 88.791% |
| ZimVie Inc. | 91.07 Million USD | 102.538% |
| Movano Inc. | -29.12 Million USD | 92.065% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 47.573% |
| Nexalin Technology, Inc. | -5.69 Million USD | 59.399% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 34.495% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 98.813% |
| Profound Medical Corp. | -27.12 Million USD | 91.48% |
| Insulet Corporation | 323.6 Million USD | 100.714% |
| enVVeno Medical Corporation | -25.01 Million USD | 90.763% |
| Surmodics, Inc. | 1.18 Million USD | 294.529% |
| iCAD, Inc. | -6.56 Million USD | 64.798% |
| Nuwellis, Inc. | -16.35 Million USD | 85.871% |
| Biotricity, Inc. | -8.82 Million USD | 73.823% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 97.614% |
| Aethlon Medical, Inc. | -11.84 Million USD | 80.496% |
| InspireMD, Inc. | -20.91 Million USD | 88.948% |
| PAVmed Inc. | -75.74 Million USD | 96.949% |
| BIOLASE, Inc. | -15.13 Million USD | 84.735% |
| Beyond Air, Inc. | -59.03 Million USD | 96.085% |
| FONAR Corporation | 28.25 Million USD | 108.18% |
| AxoGen, Inc. | -13.32 Million USD | 82.661% |
| Vivani Medical, Inc. | -26.6 Million USD | 91.315% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 109.417% |
| Inari Medical, Inc. | 7.11 Million USD | 132.49% |
| UFP Technologies, Inc. | 72.74 Million USD | 103.177% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 31.744% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 62.459% |
| Tenon Medical, Inc. | -15.52 Million USD | 85.117% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 84.862% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 94.428% |
| AdaptHealth Corp. | -171.09 Million USD | 98.649% |
| Sintx Technologies, Inc. | -6.6 Million USD | 64.985% |
| NanoVibronix, Inc. | -3.43 Million USD | 32.722% |
| Quanterix Corporation | -38.08 Million USD | 93.932% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 78.74% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 7803.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 99.167% |
| TransMedics Group, Inc. | -7.6 Million USD | 69.604% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 89.382% |
| NeuroMetrix, Inc. | -7.09 Million USD | 67.431% |
| Hyperfine, Inc. | -47.06 Million USD | 95.089% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 96.036% |
| Biomerica, Inc. | -5.99 Million USD | 61.438% |
| Bone Biologics Corporation | 479.57 Thousand USD | 581.888% |
| AVITA Medical, Inc. | -39.56 Million USD | 94.159% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 74.806% |
| Silk Road Medical, Inc | -45.08 Million USD | 94.874% |